首页 > 最新文献

Cerebrovascular Diseases Extra最新文献

英文 中文
Recurrent Stroke Prevention Strategies in Patients Receiving Acute Stroke Reperfusion Therapies (CoPrime Study Survey). 急性卒中再灌注治疗患者复发性卒中预防策略(copprime研究调查)。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-05-30 DOI: 10.1159/000546654
Rezan Ashayeri Ahmadabad, Mohammed Almekhlafi, P N Sylaja, Aviraj Deshmukh, Jesse Dawson, Aleksandra Pikula, Muhammad Shazam Hussain, Yiran Zhang, Negar Asdaghi, Sung-Ii Sohn, Mohammad Wasay, Ashfaq Shuaib, Brian Buck, Mahesh Pundlik Kate

Introduction: Patients who have undergone reperfusion treatments, like all ischemic stroke patients, are at risk of recurrent ischemic strokes in the first 90 days. Current guidelines recommend single antiplatelet therapy for secondary prevention at variable time points after the procedure. This study assessed the practices and perspectives of healthcare professionals on the use of dual antiplatelet therapy in patients with non-cardioembolic ischemic stroke who have undergone reperfusion therapy.

Methods: We conducted a multinational cross-sectional web-based survey using Qualtrics involving neurologists and non-neurologist stroke physicians (including neurosurgeons, interventional neuroradiologists, and internal medicine physicians). Participants were asked about their current practices and presented with six structured case scenarios to determine their treatment preferences. In the case scenarios, we assessed their willingness to randomize to a clinical trial comparing single versus dual antiplatelets. Multinomial logistic regression analysis was performed to assess the relationship between demographic characteristics and willingness to randomize.

Results: A total of 278 clinicians from 26 countries participated in the survey. The most common continent of practice was Asia (155/278; 55.9%). The most common area of practice was neurology (220/278; 79.1%), with most participants having 5-15 years of experience (115/278; 41.5%) and working in comprehensive stroke centers (205/278; 73.9%). Antiplatelet Choice: For a small infarct post-intravenous thrombolysis and endovascular thrombectomy (EVT), 194/278 (69.8%) preferred aspirin, and 49/278 (17.6%) chose a dual antiplatelet strategy with aspirin and clopidogrel. Loading of Antiplatelet: A total of 121/278 (43.5%) indicated they would not administer a loading dose in cases even with small final infarctions. Timing of Antiplatelet Initiation: Preferences varied; 61/278 (21.7%) considered early initiation immediately post-EVT, and 103/278 (37.2%) considered 24 h post-EVT. Willingness to Randomize: A total of 16/278 (77.7%) were willing or would consider randomizing in a clinical trial with dual antiplatelet. On regression analyses, the willingness to randomize was influenced by years of practice and the local volume of reperfusion therapy.

Conclusion: Antiplatelet management for secondary stroke prevention in patients with non-cardioembolic ischemic stroke following reperfusion therapy is variable. However, more than three-fourths of participants were willing to consider randomization to a clinical trial exploring the prevention of recurrent stroke after reperfusion therapy.

背景:与所有缺血性脑卒中患者一样,接受再灌注治疗的患者在前90天有复发性缺血性脑卒中的风险。目前的指南推荐在手术后可变时间点进行单一抗血小板治疗作为二级预防。本研究旨在调查医疗保健专业人员,以评估在接受再灌注治疗的患者中使用双重抗血小板治疗的做法和观点。方法:我们使用Qualtrics进行了一项跨国横断面网络调查,涉及神经科医生和非神经科中风医生(包括神经外科医生、介入神经放射学家和内科医生)。参与者被问及他们目前的做法,并提出了六个结构化的案例方案,以确定他们的治疗偏好。在这种情况下,我们评估了他们随机参加比较单抗血小板和双抗血小板临床试验的意愿。采用多项逻辑回归分析来评估人口统计学特征与随机化意愿之间的关系。结果:来自26个国家的278名临床医生参与了调查。最常见的执业大陆为亚洲(55.9%),执业领域为神经内科(79.1%),执业年限为5-15年(41.5%),卒中中心级别为综合卒中中心(73.9%)。抗血小板选择:对于ivt和EVT后的小梗死,69.8%的人首选阿司匹林,17.6%的人选择阿司匹林和氯吡格雷的双重抗血小板策略。抗血小板负荷:43.5%的人表示即使最终梗死灶很小,他们也不会给予负荷剂量。抗血小板起始时间:偏好不同;21.7%的人认为evt后立即开始治疗,37.2%的人认为evt后24小时开始治疗。随机化意愿:77.7%的人愿意或会考虑在双抗血小板临床试验中随机化。在回归分析中,随机化的意愿受到实践年限和局部再灌注治疗量的影响。结论:再灌注治疗后继发性脑卒中预防的抗血小板管理是可变的。然而,超过四分之三的参与者愿意考虑随机化,参与一项探讨预防再灌注治疗后卒中复发的临床试验。
{"title":"Recurrent Stroke Prevention Strategies in Patients Receiving Acute Stroke Reperfusion Therapies (CoPrime Study Survey).","authors":"Rezan Ashayeri Ahmadabad, Mohammed Almekhlafi, P N Sylaja, Aviraj Deshmukh, Jesse Dawson, Aleksandra Pikula, Muhammad Shazam Hussain, Yiran Zhang, Negar Asdaghi, Sung-Ii Sohn, Mohammad Wasay, Ashfaq Shuaib, Brian Buck, Mahesh Pundlik Kate","doi":"10.1159/000546654","DOIUrl":"10.1159/000546654","url":null,"abstract":"<p><strong>Introduction: </strong>Patients who have undergone reperfusion treatments, like all ischemic stroke patients, are at risk of recurrent ischemic strokes in the first 90 days. Current guidelines recommend single antiplatelet therapy for secondary prevention at variable time points after the procedure. This study assessed the practices and perspectives of healthcare professionals on the use of dual antiplatelet therapy in patients with non-cardioembolic ischemic stroke who have undergone reperfusion therapy.</p><p><strong>Methods: </strong>We conducted a multinational cross-sectional web-based survey using Qualtrics involving neurologists and non-neurologist stroke physicians (including neurosurgeons, interventional neuroradiologists, and internal medicine physicians). Participants were asked about their current practices and presented with six structured case scenarios to determine their treatment preferences. In the case scenarios, we assessed their willingness to randomize to a clinical trial comparing single versus dual antiplatelets. Multinomial logistic regression analysis was performed to assess the relationship between demographic characteristics and willingness to randomize.</p><p><strong>Results: </strong>A total of 278 clinicians from 26 countries participated in the survey. The most common continent of practice was Asia (155/278; 55.9%). The most common area of practice was neurology (220/278; 79.1%), with most participants having 5-15 years of experience (115/278; 41.5%) and working in comprehensive stroke centers (205/278; 73.9%). Antiplatelet Choice: For a small infarct post-intravenous thrombolysis and endovascular thrombectomy (EVT), 194/278 (69.8%) preferred aspirin, and 49/278 (17.6%) chose a dual antiplatelet strategy with aspirin and clopidogrel. Loading of Antiplatelet: A total of 121/278 (43.5%) indicated they would not administer a loading dose in cases even with small final infarctions. Timing of Antiplatelet Initiation: Preferences varied; 61/278 (21.7%) considered early initiation immediately post-EVT, and 103/278 (37.2%) considered 24 h post-EVT. Willingness to Randomize: A total of 16/278 (77.7%) were willing or would consider randomizing in a clinical trial with dual antiplatelet. On regression analyses, the willingness to randomize was influenced by years of practice and the local volume of reperfusion therapy.</p><p><strong>Conclusion: </strong>Antiplatelet management for secondary stroke prevention in patients with non-cardioembolic ischemic stroke following reperfusion therapy is variable. However, more than three-fourths of participants were willing to consider randomization to a clinical trial exploring the prevention of recurrent stroke after reperfusion therapy.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"162-172"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12237293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144200392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Symptomatic Intracranial Large Artery Stenoses: A Prospective Cohort Study from the Asian Registry of Intracranial Atherosclerosis. 无症状颅内大动脉狭窄的预后:来自亚洲颅内动脉粥样硬化登记处(ARICAS)的前瞻性队列研究。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2024-12-19 DOI: 10.1159/000543144
Jose C Navarro, Jeyaraj D Pandian, Nijasri C Suwanwela, Tsong-Hai Lee, Kay Sin Tan, Narayanaswamy Venketasubramanian

Introduction: Intracranial large artery atherosclerosis (ICAS) is a common cause of stroke in Asia. Prior epidemiological publications on ICAS have largely been single-country reports. This collaborative study involving several Asian countries aims to investigate the characteristics and outcomes of patients with stroke attributable to ICAS.

Methods: This is an international, multicenter, observational, prospective cohort study of patients admitted with acute ischemic stroke secondary to ICAS to stroke centers in six Asian countries. Stroke due to ICAS was diagnosed when there was a ≥50% intracranial large artery stenosis ipslateral to a non-lacunar infarct, without significant ipsilateral extracranial stenosis, cardiac cause or other mechanism found for the stroke. Data were collected on patient demographics, vascular risk factors, stroke location, and severity. Outcomes of interest were stroke recurrence and mortality at 12-month follow-up.

Results: A total of 356 patients were recruited. Mean age was 62.7 ± 13.8 years, and 39.9% were females. Mean NIHSS on admission was 9 ± 8, with majority of patients having mild (39.3%) or moderate (37.9%) strokes. Stroke recurrence was 6.7% (95% CI: 4.4-9.9%) while mortality rate was 13.2% (95% CI: 9.9-17.2%) within 1 year. The risk of stroke recurrence was associated with increasing age (odds ratio [OR]: 1.04, 95% CI: 1-1.06, p = 0.05) and hypertension (OR: 3.23, 95% CI: 1.09-9.61, p = 0.035). Mortality was associated with age (OR: 1.05, 95% CI: 1.01-1.08, p = 0.006) and NIHSS (OR: 1.12, 95% CI: 1.07-1.17, p < 0.001).

Conclusions: This multicenter Asian study demonstrates a high risk of stroke recurrence and mortality among patients with acute stroke due to ICAS. They are associated with age (both), as well as hypertension (for recurrence) and NIHSS (for mortality). Better treatment modalities are needed to reduce the frequency of adverse outcomes in symptomatic ICAS.

颅内大动脉粥样硬化(ICAS)是亚洲中风的常见原因。以前关于ICAS的流行病学出版物大多是单一国家的报告。这项涉及多个亚洲国家的合作研究旨在调查由ICAS引起的脑卒中患者的特征和结果。方法:这是一项国际、多中心、观察性、前瞻性队列研究,研究对象是6个亚洲国家卒中中心收治的继发于ICAS的急性缺血性卒中患者。当颅内大动脉狭窄与非腔隙性梗死同侧同时出现bbb50 %颅内大动脉狭窄时,诊断为ICAS所致卒中,未发现明显的同侧颅外狭窄、心脏原因或其他机制导致卒中。收集了患者人口统计学、血管危险因素、中风部位和严重程度的数据。随访12个月后的结果为卒中复发率和死亡率。结果:共纳入356例患者。平均年龄62.7岁13.8岁,女性占39.9%。入院时NIHSS平均值为9 + 8,大多数患者为轻度(39.3%)或中度(37.9%)卒中。1年内卒中复发率为6.7% (95%CI 4.4 ~ 9.9%),死亡率为13.2% (95%CI 9.9 ~ 17.2%)。卒中复发风险与年龄增加(比值比OR 1.04, 95%CI 1 ~ 1.06, p = 0.05)和高血压(比值比OR 3.23, 95%CI 1.09 ~ 9.61, p = 0.035)相关。死亡率与年龄(OR 1.05, 95%CI 1.01 - 1.08, p = 0.006)和NIHSS (OR 1.12, 95%CI 1.07 - 1.17, p)相关。结论:这项亚洲多中心研究表明,ICAS导致的急性卒中患者卒中复发和死亡率风险较高。它们与年龄(两者)、高血压(复发)和NIHSS(死亡率)有关。需要更好的治疗方式来减少症状性ICAS不良后果的发生频率。
{"title":"Outcomes of Symptomatic Intracranial Large Artery Stenoses: A Prospective Cohort Study from the Asian Registry of Intracranial Atherosclerosis.","authors":"Jose C Navarro, Jeyaraj D Pandian, Nijasri C Suwanwela, Tsong-Hai Lee, Kay Sin Tan, Narayanaswamy Venketasubramanian","doi":"10.1159/000543144","DOIUrl":"10.1159/000543144","url":null,"abstract":"<p><strong>Introduction: </strong>Intracranial large artery atherosclerosis (ICAS) is a common cause of stroke in Asia. Prior epidemiological publications on ICAS have largely been single-country reports. This collaborative study involving several Asian countries aims to investigate the characteristics and outcomes of patients with stroke attributable to ICAS.</p><p><strong>Methods: </strong>This is an international, multicenter, observational, prospective cohort study of patients admitted with acute ischemic stroke secondary to ICAS to stroke centers in six Asian countries. Stroke due to ICAS was diagnosed when there was a ≥50% intracranial large artery stenosis ipslateral to a non-lacunar infarct, without significant ipsilateral extracranial stenosis, cardiac cause or other mechanism found for the stroke. Data were collected on patient demographics, vascular risk factors, stroke location, and severity. Outcomes of interest were stroke recurrence and mortality at 12-month follow-up.</p><p><strong>Results: </strong>A total of 356 patients were recruited. Mean age was 62.7 ± 13.8 years, and 39.9% were females. Mean NIHSS on admission was 9 ± 8, with majority of patients having mild (39.3%) or moderate (37.9%) strokes. Stroke recurrence was 6.7% (95% CI: 4.4-9.9%) while mortality rate was 13.2% (95% CI: 9.9-17.2%) within 1 year. The risk of stroke recurrence was associated with increasing age (odds ratio [OR]: 1.04, 95% CI: 1-1.06, p = 0.05) and hypertension (OR: 3.23, 95% CI: 1.09-9.61, p = 0.035). Mortality was associated with age (OR: 1.05, 95% CI: 1.01-1.08, p = 0.006) and NIHSS (OR: 1.12, 95% CI: 1.07-1.17, p < 0.001).</p><p><strong>Conclusions: </strong>This multicenter Asian study demonstrates a high risk of stroke recurrence and mortality among patients with acute stroke due to ICAS. They are associated with age (both), as well as hypertension (for recurrence) and NIHSS (for mortality). Better treatment modalities are needed to reduce the frequency of adverse outcomes in symptomatic ICAS.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"30-38"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Associated Factors of Extracranial Carotid Stenosis in Northern Vietnamese Patients with Transient Ischemic Attack or Ischemic Stroke. 越南北部短暂性脑缺血发作或缺血性脑卒中患者颅外颈动脉狭窄的患病率及相关因素
IF 2.1 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-09-04 DOI: 10.1159/000548297
Mai Duy Ton, Pham Manh Hung, Thanh N Nguyen, Bui Nguyen Tung

Introduction: In Vietnam, the incidence of transient ischemic attack (TIA) or ischemic stroke has increased in recent years due to lifestyle changes. Carotid stenosis is a common cause of TIA/ischemic stroke. This study aimed to determine the prevalence and identify risk factors for ipsilateral internal carotid artery (ICA) stenosis in patients with TIA or ischemic stroke.

Methods: We recruited consecutive patients admitted to Bach Mai hospital from June/2021 to June/2022 with the diagnosis of TIA/ischemic stroke. The primary outcome was the presence of significant ipsilateral carotid stenosis (≥50%) by using carotid imaging modalities (duplex ultrasonography, computed tomography angiography, or magnetic resonance angiography). Univariable and multivariable logistic regression analyses were performed to identify risk factors associated with 50-99% ICA stenosis.

Results: In total, 1,191 consecutive patients with TIA/ischemic stroke were included. Of these, 62 (5.2%, 95% confidence interval [CI]: 4.0-6.6) had 50-99% ipsilateral ICA stenosis. Patients with significant ICA stenosis were more likely to have advanced age, male sex, and prior stroke. In multivariable logistic regression, advanced age (OR 1.49 per 10-year increment; 95% CI: 1.17-1.90, p = 0.001), male sex (OR 4.94; 95% CI: 2.15-11.38, p < 0.001), and prior stroke (OR 2.01; 95% CI: 1.12-3.62, p = 0.02) were risk factors for ICA stenosis.

Conclusion: The observed prevalence of extracranial ICA stenosis in TIA/ischemic stroke patients in Vietnam appears to be lower compared to Western nations, yet it is relatively comparable to that of other Asian countries. Male sex, prior stroke, and advanced age constitute significant risk factors for symptomatic ICA stenosis.

.

背景:在越南,由于生活方式的改变,短暂性脑缺血发作(TIA)或缺血性脑卒中的发病率近年来有所增加。颈动脉狭窄是TIA/缺血性中风的常见原因。本研究旨在确定短暂性脑缺血发作(TIA)或缺血性脑卒中患者同侧颈内动脉(ICA)狭窄的患病率和危险因素。方法:我们招募了2021年6月至2022年6月在巴赫迈医院确诊为TIA/缺血性脑卒中的连续患者。主要结果是通过颈动脉成像方式(双工超声、计算机断层血管成像或磁共振血管成像)发现明显的同侧颈动脉狭窄(≥50%)。进行单变量和多变量logistic回归分析,以确定与50-99% ICA狭窄相关的危险因素。结果:共纳入1191例连续TIA/缺血性脑卒中患者。其中,62例(5.2%,95%可信区间(CI): 4.0-6.6)有50-99%的同侧ICA狭窄。有明显ICA狭窄的患者更可能有高龄、男性和既往卒中。在多变量logistic回归中,高龄(OR为1.49 / 10年;CI 95%: 1.17 -1.90, p= 0.001)、男性(OR为4.94;CI 95%: 2.15 - 11.38, p < 0.001)和既往卒中(OR为2.01;CI 95%: 1.12 -3.62, p= 0.02)是ICA狭窄的危险因素。结论:与西方国家相比,越南观察到的TIA/缺血性卒中患者颅内外ICA狭窄的患病率似乎较低,但与其他亚洲国家相对相当。男性、既往卒中和高龄是症状性ICA狭窄的重要危险因素。
{"title":"Prevalence and Associated Factors of Extracranial Carotid Stenosis in Northern Vietnamese Patients with Transient Ischemic Attack or Ischemic Stroke.","authors":"Mai Duy Ton, Pham Manh Hung, Thanh N Nguyen, Bui Nguyen Tung","doi":"10.1159/000548297","DOIUrl":"10.1159/000548297","url":null,"abstract":"<p><p><p>Introduction: In Vietnam, the incidence of transient ischemic attack (TIA) or ischemic stroke has increased in recent years due to lifestyle changes. Carotid stenosis is a common cause of TIA/ischemic stroke. This study aimed to determine the prevalence and identify risk factors for ipsilateral internal carotid artery (ICA) stenosis in patients with TIA or ischemic stroke.</p><p><strong>Methods: </strong>We recruited consecutive patients admitted to Bach Mai hospital from June/2021 to June/2022 with the diagnosis of TIA/ischemic stroke. The primary outcome was the presence of significant ipsilateral carotid stenosis (≥50%) by using carotid imaging modalities (duplex ultrasonography, computed tomography angiography, or magnetic resonance angiography). Univariable and multivariable logistic regression analyses were performed to identify risk factors associated with 50-99% ICA stenosis.</p><p><strong>Results: </strong>In total, 1,191 consecutive patients with TIA/ischemic stroke were included. Of these, 62 (5.2%, 95% confidence interval [CI]: 4.0-6.6) had 50-99% ipsilateral ICA stenosis. Patients with significant ICA stenosis were more likely to have advanced age, male sex, and prior stroke. In multivariable logistic regression, advanced age (OR 1.49 per 10-year increment; 95% CI: 1.17-1.90, p = 0.001), male sex (OR 4.94; 95% CI: 2.15-11.38, p < 0.001), and prior stroke (OR 2.01; 95% CI: 1.12-3.62, p = 0.02) were risk factors for ICA stenosis.</p><p><strong>Conclusion: </strong>The observed prevalence of extracranial ICA stenosis in TIA/ischemic stroke patients in Vietnam appears to be lower compared to Western nations, yet it is relatively comparable to that of other Asian countries. Male sex, prior stroke, and advanced age constitute significant risk factors for symptomatic ICA stenosis. </p>.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"210-217"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between Neuroimaging Scores and Carotid Artery Ultrasound Features in Cerebral Small Vessel Disease Patients. 脑血管病患者神经影像学评分与颈动脉超声特征的相关性研究
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-01-02 DOI: 10.1159/000543355
Yun Xu, Yifan Song, Tieqi Tang, Weili Jia, Huijuan Xu, Yu Li, Yu Guo, Xiaorui Wang, Ruihong Liu

Introduction: The recently proposed cerebral small vessel disease (CSVD) score system may help capture the overall burden of CSVD. This study aimed to investigate the associations between carotid artery ultrasound features and the burden score and cognitive performance of CSVD patients.

Methods: This is a cross-sectional analysis of an ongoing prospective study. From May 2019 to October 2023, 287 patients with at least one neuroimaging marker of CSVD were recruited and underwent carotid ultrasound examination, brain magnetic resonance imaging (MRI) scans, and neuropsychological assessment. Carotid artery properties, including carotid plaque, intima-media thickness (IMT), β stiffness index (β-index), Peterson's elastic modulus (PEM), and pulse wave velocity-β (PWV-β), were calculated. The CSVD score was graded according to MRI evaluation. Participants were classified as having cognitive impairment (CI) or normal cognitive function (NCF) according to Montreal Cognitive Assessment (MoCA) scale.

Results: A total of 209 eligible patients were included in the final analysis. A significant difference was revealed regarding the CSVD score between CI and NCF participants (p < 0.001). After adjusted for covariates, increased IMT (OR = 1.11, 95% CI: 1.04-1.37, p = 0.030) and PWV-β (OR = 1.24, 95% CI: 1.09-1.51, p = 0.006) were both associated with the presence of CI. IMT and PWV-β were also associated with worse performance on attention and processing speed (IMT: β = -0.13, p = 0.011; PWV-β: β = -0.21, p = 0.011), and executive function (IMT: β = -0.20, p = 0.024; PWV-β: β = -0.33, p = 0.008). Additionally, PEM was negatively associated with executive function (β = -0.20, p = 0.009). Furthermore, binary logistic regression indicated that IMT (OR = 1.45, 95% CI: 1.18-2.01, p = 0.006), β-index (OR = 1.30, 95% CI: 1.10-1.64, p = 0.008) and PWV-β (OR = 1.23, 95% CI: 1.01-1.89, p = 0.047) were independently related to a moderate to severe CSVD burden score.

Conclusions: Carotid artery atherosclerosis and stiffness are associated with the burden score and cognitive performance of CSVD patients. Noninvasive ultrasound parameters of the carotid artery are capable of discriminating high-risk individuals with CSVD.

最近提出的脑血管疾病(CSVD)评分系统可能有助于捕获CSVD的总体负担。本研究旨在探讨颈动脉超声特征与CSVD患者负荷评分和认知能力的关系。方法:这是一项正在进行的前瞻性研究的横断面分析。2019年5月至2023年10月,招募287例至少有一种CSVD神经影像学标志物的患者,进行颈动脉超声检查、脑MRI扫描和神经心理学评估。计算颈动脉特性,包括颈动脉斑块、内膜-中膜厚度(IMT)、β刚度指数(β-index)、彼得森弹性模量(PEM)和脉搏波速度-β (PWV-β)。根据MRI评分对CSVD评分分级。根据蒙特利尔认知评估量表(MoCA)将受试者分为认知功能障碍(CI)和正常认知功能(NCF)两组。结果:共有209例符合条件的患者纳入最终分析。结论:颈动脉粥样硬化和僵硬度与CSVD患者的负担评分和认知表现相关。颈动脉的无创超声参数能够区分高危人群CSVD。
{"title":"Correlation between Neuroimaging Scores and Carotid Artery Ultrasound Features in Cerebral Small Vessel Disease Patients.","authors":"Yun Xu, Yifan Song, Tieqi Tang, Weili Jia, Huijuan Xu, Yu Li, Yu Guo, Xiaorui Wang, Ruihong Liu","doi":"10.1159/000543355","DOIUrl":"10.1159/000543355","url":null,"abstract":"<p><strong>Introduction: </strong>The recently proposed cerebral small vessel disease (CSVD) score system may help capture the overall burden of CSVD. This study aimed to investigate the associations between carotid artery ultrasound features and the burden score and cognitive performance of CSVD patients.</p><p><strong>Methods: </strong>This is a cross-sectional analysis of an ongoing prospective study. From May 2019 to October 2023, 287 patients with at least one neuroimaging marker of CSVD were recruited and underwent carotid ultrasound examination, brain magnetic resonance imaging (MRI) scans, and neuropsychological assessment. Carotid artery properties, including carotid plaque, intima-media thickness (IMT), β stiffness index (β-index), Peterson's elastic modulus (PEM), and pulse wave velocity-β (PWV-β), were calculated. The CSVD score was graded according to MRI evaluation. Participants were classified as having cognitive impairment (CI) or normal cognitive function (NCF) according to Montreal Cognitive Assessment (MoCA) scale.</p><p><strong>Results: </strong>A total of 209 eligible patients were included in the final analysis. A significant difference was revealed regarding the CSVD score between CI and NCF participants (p < 0.001). After adjusted for covariates, increased IMT (OR = 1.11, 95% CI: 1.04-1.37, p = 0.030) and PWV-β (OR = 1.24, 95% CI: 1.09-1.51, p = 0.006) were both associated with the presence of CI. IMT and PWV-β were also associated with worse performance on attention and processing speed (IMT: β = -0.13, p = 0.011; PWV-β: β = -0.21, p = 0.011), and executive function (IMT: β = -0.20, p = 0.024; PWV-β: β = -0.33, p = 0.008). Additionally, PEM was negatively associated with executive function (β = -0.20, p = 0.009). Furthermore, binary logistic regression indicated that IMT (OR = 1.45, 95% CI: 1.18-2.01, p = 0.006), β-index (OR = 1.30, 95% CI: 1.10-1.64, p = 0.008) and PWV-β (OR = 1.23, 95% CI: 1.01-1.89, p = 0.047) were independently related to a moderate to severe CSVD burden score.</p><p><strong>Conclusions: </strong>Carotid artery atherosclerosis and stiffness are associated with the burden score and cognitive performance of CSVD patients. Noninvasive ultrasound parameters of the carotid artery are capable of discriminating high-risk individuals with CSVD.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"93-101"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Ischemic Stroke in Japanese Young Adults. 日本年轻人缺血性脑卒中的临床特征
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-04-29 DOI: 10.1159/000546037
Tomoyuki Ohara, Naoki Makita, Jun Fujinami, Keiko Maezono-Kandori, Daiki Fukunaga, Eijirou Tanaka, Akihiro Fujii, Hidesato Takezawa, Naoki Tokuda, Takehiro Yamada, Shiori Ogura, Masahiro Makino, Yoshinari Nagakane, Keisuke Imai, Ikuko Mizuta, Toshiki Mizuno

Introduction: There are limited data on the characteristics of stroke in young adults in East Asia including Japan. We aimed to clarify the clinical characteristics of ischemic stroke in Japanese young adults.

Methods: We prospectively enrolled ischemic stroke patients aged 18-50 years old who were admitted to 5 high-volume stroke centers within 14 days after onset between February 2018 and January 2023. We collected clinical and imaging data based on the study protocol and analyzed them for conventional and specific stroke risk factors, stroke etiology, and clinical outcome.

Results: We enrolled 275 subjects (median age, 46 years; men, 71%; full-time workers, 75%; median NIHSS score at admission, 2 points). The major risk factors were dyslipidemia (59%), hypertension (49%), and smoking (32%). Hyperhomocysteinemia, migraine, and antiphospholipid syndrome were found in 21%, 11%, and 5%, respectively. The RNF213 p.R4810K variant was identified in 4.5%. The most common stroke etiologies were small vessel occlusion (26%) and arterial dissection (25%; intracranial in 20% and extracranial in 5%). The stroke recurrence rate was 5% at 3 months. Modified Rankin scale 0-1 at 3 months was observed in 76%, whereas 61% were able to return to their previous full-time work and 31% exhibited symptoms of depression.

Conclusions: The leading stroke etiologies in young adults in Japan were small vessel occlusion and intracranial arterial dissection, which differ from those observed in Western countries. Most young stroke patients had a favorable outcome, but some of them encountered problems relating to employment or mental health after their stroke.

背景和目的关于东亚地区包括日本在内的年轻人中风特征的数据有限。我们旨在阐明日本年轻人缺血性脑卒中的临床特征。方法前瞻性纳入2018年2月至2023年1月发病后14天内入住5个大容量卒中中心的18至50岁缺血性卒中患者。我们根据研究方案收集临床和影像学资料,并分析常规和特定脑卒中危险因素、脑卒中病因和临床结果。结果纳入275名受试者(中位年龄46岁;男性,71%;全职工人占75%;入学时NIHSS分数中位数,2分)。主要危险因素是血脂异常(59%)、高血压(49%)和吸烟(32%)。高同型半胱氨酸血症、偏头痛和抗磷脂综合征分别占21%、11%和5%。RNF213 p.R4810K变异在4.5%被鉴定。最常见的中风病因是小血管闭塞(26%)和动脉夹层(25%);颅内20%,颅外5%)。3个月卒中复发率为5%。在3个月时,有76%的人观察到修改的Rankin量表0-1,而61%的人能够恢复以前的全职工作,31%的人表现出抑郁症状。结论日本年轻人脑卒中的主要病因是小血管闭塞和颅内动脉夹层,这与西方国家不同。大多数年轻中风患者的预后良好,但他们中的一些人在中风后遇到了与就业或心理健康有关的问题。
{"title":"Clinical Characteristics of Ischemic Stroke in Japanese Young Adults.","authors":"Tomoyuki Ohara, Naoki Makita, Jun Fujinami, Keiko Maezono-Kandori, Daiki Fukunaga, Eijirou Tanaka, Akihiro Fujii, Hidesato Takezawa, Naoki Tokuda, Takehiro Yamada, Shiori Ogura, Masahiro Makino, Yoshinari Nagakane, Keisuke Imai, Ikuko Mizuta, Toshiki Mizuno","doi":"10.1159/000546037","DOIUrl":"10.1159/000546037","url":null,"abstract":"<p><strong>Introduction: </strong>There are limited data on the characteristics of stroke in young adults in East Asia including Japan. We aimed to clarify the clinical characteristics of ischemic stroke in Japanese young adults.</p><p><strong>Methods: </strong>We prospectively enrolled ischemic stroke patients aged 18-50 years old who were admitted to 5 high-volume stroke centers within 14 days after onset between February 2018 and January 2023. We collected clinical and imaging data based on the study protocol and analyzed them for conventional and specific stroke risk factors, stroke etiology, and clinical outcome.</p><p><strong>Results: </strong>We enrolled 275 subjects (median age, 46 years; men, 71%; full-time workers, 75%; median NIHSS score at admission, 2 points). The major risk factors were dyslipidemia (59%), hypertension (49%), and smoking (32%). Hyperhomocysteinemia, migraine, and antiphospholipid syndrome were found in 21%, 11%, and 5%, respectively. The RNF213 p.R4810K variant was identified in 4.5%. The most common stroke etiologies were small vessel occlusion (26%) and arterial dissection (25%; intracranial in 20% and extracranial in 5%). The stroke recurrence rate was 5% at 3 months. Modified Rankin scale 0-1 at 3 months was observed in 76%, whereas 61% were able to return to their previous full-time work and 31% exhibited symptoms of depression.</p><p><strong>Conclusions: </strong>The leading stroke etiologies in young adults in Japan were small vessel occlusion and intracranial arterial dissection, which differ from those observed in Western countries. Most young stroke patients had a favorable outcome, but some of them encountered problems relating to employment or mental health after their stroke.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"154-161"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144020935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the Effect of Trimethylamine Oxide on Recurrent Cerebral Infarction of Minor Ischaemic Stroke Rats. 氧化三甲胺对小缺血性脑卒中大鼠复发性脑梗死影响的研究。
IF 2.1 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-08-26 DOI: 10.1159/000548183
Chen Chen, Ziwei Hou, Hong Liu, Jintao Wang, Jianyong Guo, Ting Yang, Min Wang, Ling Ding

Introduction: This study investigates the impact of trimethylamine oxide (TMAO) on recurrent cerebral infarction in minor ischaemic stroke (MIS).

Methods: A rat model was used, with dietary choline levels adjusted to vary TMAO levels. TMAO was quantified via liquid chromatography-mass spectrometry, and histological changes in brain and aortic tissues were analysed using HE staining.

Results: Data analysis showed that TMAO levels and neurological deficit scores increased progressively across groups, correlating positively with the severity of cerebral and arterial pathology. High choline diets significantly elevated TMAO levels, aggravating infarction and atherosclerosis, while low choline diets reduced these effects.

Conclusions: TMAO demonstrated medium-high diagnostic value for neurological deficits, infarction size, and arterial damage. These findings suggest that elevated TMAO levels are linked to worse outcomes in MIS, highlighting the potential of TMAO as a biomarker for diagnosis and prevention of recurrent cerebral infarction.

.

背景:本研究探讨氧化三甲胺(TMAO)对轻度缺血性脑卒中(MIS)复发性脑梗死的影响。方法:采用大鼠模型,调整饮食胆碱水平以改变TMAO水平。采用液相色谱-质谱法(LC-MS)定量TMAO, HE染色分析脑组织和主动脉组织的组织学变化。结果:数据分析显示,各组TMAO水平和神经功能缺损评分逐渐升高,与脑和动脉病理严重程度呈正相关。高胆碱饮食显著提高氧化三甲胺水平,加重梗死和动脉粥样硬化,而低胆碱饮食减少这些影响。结论:TMAO对神经功能缺损、梗死大小和动脉损伤具有中高的诊断价值。这些发现表明,TMAO水平升高与MIS的预后恶化有关,强调了TMAO作为诊断和预防复发性脑梗死的生物标志物的潜力。
{"title":"Study on the Effect of Trimethylamine Oxide on Recurrent Cerebral Infarction of Minor Ischaemic Stroke Rats.","authors":"Chen Chen, Ziwei Hou, Hong Liu, Jintao Wang, Jianyong Guo, Ting Yang, Min Wang, Ling Ding","doi":"10.1159/000548183","DOIUrl":"10.1159/000548183","url":null,"abstract":"<p><p><p>Introduction: This study investigates the impact of trimethylamine oxide (TMAO) on recurrent cerebral infarction in minor ischaemic stroke (MIS).</p><p><strong>Methods: </strong>A rat model was used, with dietary choline levels adjusted to vary TMAO levels. TMAO was quantified via liquid chromatography-mass spectrometry, and histological changes in brain and aortic tissues were analysed using HE staining.</p><p><strong>Results: </strong>Data analysis showed that TMAO levels and neurological deficit scores increased progressively across groups, correlating positively with the severity of cerebral and arterial pathology. High choline diets significantly elevated TMAO levels, aggravating infarction and atherosclerosis, while low choline diets reduced these effects.</p><p><strong>Conclusions: </strong>TMAO demonstrated medium-high diagnostic value for neurological deficits, infarction size, and arterial damage. These findings suggest that elevated TMAO levels are linked to worse outcomes in MIS, highlighting the potential of TMAO as a biomarker for diagnosis and prevention of recurrent cerebral infarction. </p>.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"192-201"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145034337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Thrombectomy in Vietnamese Stroke Patients Selected through Perfusion Imaging with an Onset Time between 6 and 24 Hours. 通过灌注成像挑选出发病时间在 6-24 小时之间的越南脑卒中患者进行血栓切除术的安全性和有效性。
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2024-11-19 DOI: 10.1159/000542653
Binh Nguyen Pham, Hang T Minh Tran, An Thai Thanh Nguyen, Huan Nguyen Pham, Anh Tuan Le Truong, Trung Quoc Nguyen, Huong Bich Thi Nguyen, Tri Quang Nguyen, Huy Quoc Do, Tra Vu Son Le, Vu Thanh Tran, Ryan Anh-Quang Nguyen, Huy Nguyen, Thang Ba Nguyen, Thang Huy Nguyen

Introduction: Recent trials have demonstrated the remarkable benefit of endovascular treatment (EVT) up to 24 h in patients with large vessel occlusion (LVO) and target mismatch profiles; however, benefits of late-window EVT in Vietnamese population remain poorly understood. This study aims to evaluate the real-world outcomes of EVT in acute ischemic stroke (AIS) patients selected using perfusion imaging within the 6-24-h window.

Methods: This is a prospective study of consecutive patients with anterior circulation LVO stroke who underwent EVT within 6-24 h after last known well between August 2022 and March 2024. Patients were selected based on the DAWN/DEFUSE-3 criteria (Perfusion-RAPID, iSchemaView). The primary outcome was the proportion of patients with functional independence at 90 days (modified Rankin Scale score of 0-2). The secondary outcomes were successful reperfusion defined by thrombolysis in cerebral infarction (TICI) ≥2b on the final procedure and subgroup analysis between good (hypoperfusion intensity ratio [HIR] <0.4) and poor collaterals (HIR ≥0.4) groups. Safety outcomes were mortality rate and symptomatic intracranial hemorrhage (sICH).

Results: Of 122 enrolled patients, 68% met inclusion criteria of DEFUSE-3 trial, 61% met DAWN trial criteria. Mean age was 66 years, median baseline NIHSS was 13, median time from stroke onset to hospital arrival was 12.55 h (9.50-16.48), and median infarct volume was 11.5 mL. The rate of functional independence at 90 days was 45.9%. Successful reperfusion (TICI score of ≥2b) was achieved by 83.6% of cases. The 90-day mortality rate was 10.7%; sICH was reported in 8 patients (6.6%). Patients with good collaterals had better functional outcome.

Conclusions: This real-world observational study suggests that late-window EVT may be safe and effective in eligible Vietnamese patients selected based on perfusion imaging, thus supporting its practical use in this patient population. HIR is a robust indicator of collateral status and could made it a valuable addition to stroke imaging workup in clinical setting.

导言:最近的试验表明,血管内治疗(EVT)对大血管闭塞(LVO)和靶点不匹配患者在 24 小时内的治疗效果显著;然而,越南人对晚窗口 EVT 的疗效仍知之甚少。本研究旨在评估利用灌注成像技术选择的急性缺血性卒中(AIS)患者在 6 至 24 小时窗口期进行 EVT 的实际效果。方法 对 2022 年 8 月至 2024 年 3 月间最后一次已知脑卒中后 6-24 小时内接受 EVT 的连续前循环 LVO 脑卒中患者进行前瞻性研究。患者根据 DAWN/DEFUSE-3 标准(Perfusion-RAPID,iSchemaView)筛选。主要结果是 90 天后功能独立的患者比例(修改后的 Rankin 量表评分为 0-2)。次要结果是最终手术中脑梗塞溶栓(TICI)≥2b的再灌注成功率,以及良好(低灌注强度比值(HIR))与不良(低灌注强度比值(HIR))之间的亚组分析。
{"title":"Safety and Efficacy of Thrombectomy in Vietnamese Stroke Patients Selected through Perfusion Imaging with an Onset Time between 6 and 24 Hours.","authors":"Binh Nguyen Pham, Hang T Minh Tran, An Thai Thanh Nguyen, Huan Nguyen Pham, Anh Tuan Le Truong, Trung Quoc Nguyen, Huong Bich Thi Nguyen, Tri Quang Nguyen, Huy Quoc Do, Tra Vu Son Le, Vu Thanh Tran, Ryan Anh-Quang Nguyen, Huy Nguyen, Thang Ba Nguyen, Thang Huy Nguyen","doi":"10.1159/000542653","DOIUrl":"10.1159/000542653","url":null,"abstract":"<p><strong>Introduction: </strong>Recent trials have demonstrated the remarkable benefit of endovascular treatment (EVT) up to 24 h in patients with large vessel occlusion (LVO) and target mismatch profiles; however, benefits of late-window EVT in Vietnamese population remain poorly understood. This study aims to evaluate the real-world outcomes of EVT in acute ischemic stroke (AIS) patients selected using perfusion imaging within the 6-24-h window.</p><p><strong>Methods: </strong>This is a prospective study of consecutive patients with anterior circulation LVO stroke who underwent EVT within 6-24 h after last known well between August 2022 and March 2024. Patients were selected based on the DAWN/DEFUSE-3 criteria (Perfusion-RAPID, iSchemaView). The primary outcome was the proportion of patients with functional independence at 90 days (modified Rankin Scale score of 0-2). The secondary outcomes were successful reperfusion defined by thrombolysis in cerebral infarction (TICI) ≥2b on the final procedure and subgroup analysis between good (hypoperfusion intensity ratio [HIR] <0.4) and poor collaterals (HIR ≥0.4) groups. Safety outcomes were mortality rate and symptomatic intracranial hemorrhage (sICH).</p><p><strong>Results: </strong>Of 122 enrolled patients, 68% met inclusion criteria of DEFUSE-3 trial, 61% met DAWN trial criteria. Mean age was 66 years, median baseline NIHSS was 13, median time from stroke onset to hospital arrival was 12.55 h (9.50-16.48), and median infarct volume was 11.5 mL. The rate of functional independence at 90 days was 45.9%. Successful reperfusion (TICI score of ≥2b) was achieved by 83.6% of cases. The 90-day mortality rate was 10.7%; sICH was reported in 8 patients (6.6%). Patients with good collaterals had better functional outcome.</p><p><strong>Conclusions: </strong>This real-world observational study suggests that late-window EVT may be safe and effective in eligible Vietnamese patients selected based on perfusion imaging, thus supporting its practical use in this patient population. HIR is a robust indicator of collateral status and could made it a valuable addition to stroke imaging workup in clinical setting.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"9-18"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11666263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency Department Workflow Times of Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Prospective Cohort Study before and during the COVID-19 Pandemic. 急诊用替奈普酶静脉溶栓与阿替普酶治疗急性缺血性卒中的工作时间:一项2019冠状病毒病大流行之前和期间的前瞻性队列研究
IF 2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-02-03 DOI: 10.1159/000543900
Matias Guzman, Pablo M Lavados, Gabriel Cavada, Alejandro M Brunser, Veronica V Olavarria
<p><strong>Introduction: </strong>Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.</p><p><strong>Methods: </strong>We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with ALT in the period immediately before. We compared emergency department length of stay (EDLOS), door-to-needle time (DTN), door-to-groin puncture time (DTG), clinical and safety outcomes with adjusted general linear regression models.</p><p><strong>Results: </strong>110 patients treated with TNK and 111 with ALT were included in this study. Mean EDLOS was 251 (SD = 164) min for TNK users versus 240 (SD = 148) min for ALT (p = 0.62). Mean DTN was 43 (SD = 25) min for TNK versus 46 (SD = 27) min for ALT users (p = 0.39). Mean DTN under 60 min was achieved in 86 (78.2%) patients and in 85 (76.5%) patients of the TNK and ALT groups, respectively (p = 1.0). DTN under 45 min was achieved in 65.4% and 58.6% (p = 0.65) of the TNK and ALT groups, respectively. DTG time was 114 (SD = 43) min for TNK versus 111 (58 = SD) min in the ALT group (p = 0.88). DTG under 90 min was achieved in 32% of the TNK group and 35% of the ALT group (p = 0.69). There were no differences in any of the clinical or safety outcomes between groups at 90 days.</p><p><strong>Conclusions: </strong>The adoption of TNK during COVID-19 pandemic did not result in a change in EDLOS, DTN, or DTG times when compared to ALT in this cohort. Safety and clinical outcomes were similar between groups. Probably a greater benefit could have been seen in a drip and ship thrombolysis setting. Further research is needed to assess the potential advantages of TNK in drip and ship scenarios of IVT.</p><p><strong>Introduction: </strong>Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.</p><p><strong>Methods: </strong>We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with A
在急性缺血性卒中(AIS)的静脉溶栓(IVT)治疗中,Tenecteplase (TNK)已被证明优于阿替普酶(ALT)。使用TNK有潜在的工作流程优势,旨在减少患者在急诊科的住院时间。我们的目的是调查在COVID-19大流行期间,与历史上使用ALT相比,常规使用TNK是否会影响工作时间,同时在综合卒中中心的非点滴和船舶场景中保持非差的临床结果。方法:我们纳入2019年9月至2022年9月入院的AIS患者,并将COVID-19大流行期间接受TNK治疗的患者与之前接受ALT治疗的患者进行比较。我们比较急诊科住院时间(EDLOS)、门到针时间(DTN)、门到腹股沟穿刺时间(DTG)、临床和安全结果与调整后的一般线性回归模型。结果:110例患者接受TNK治疗,111例患者接受ALT治疗。TNK患者的平均EDLOS为251 (SD=164)分钟,ALT患者为240 (SD=148)分钟(p=0.62)。TNK组的平均DTN为43 (SD=25)分钟,ALT组为46 (SD=27)分钟(p=0.39)。TNK组和ALT组60分钟内平均DTN分别为86例(78.2%)和85例(76.5%)(p=1.0)。TNK组和ALT组45分钟内DTN分别达到65.4%和58.6% (p=0.65)。TNK组的DTG时间为114 (SD=43)分钟,ALT组为111 (58=SD)分钟(p=0.88)。TNK组和ALT组在90分钟内达到DTG的比例分别为32%和35% (p=0.69)。在90天时,两组之间的任何临床或安全性结果均无差异。结论:在该队列中,与ALT相比,在COVID - 19大流行期间采用TNK并未导致EDLOS、DTN或DTG时间的变化。两组间的安全性和临床结果相似。也许在点滴溶栓和船溶栓中可以看到更大的益处。需要进一步的研究来评估TNK在IVT滴注和船载方案中的潜在优势。
{"title":"Emergency Department Workflow Times of Intravenous Thrombolysis with Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Prospective Cohort Study before and during the COVID-19 Pandemic.","authors":"Matias Guzman, Pablo M Lavados, Gabriel Cavada, Alejandro M Brunser, Veronica V Olavarria","doi":"10.1159/000543900","DOIUrl":"10.1159/000543900","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with ALT in the period immediately before. We compared emergency department length of stay (EDLOS), door-to-needle time (DTN), door-to-groin puncture time (DTG), clinical and safety outcomes with adjusted general linear regression models.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;110 patients treated with TNK and 111 with ALT were included in this study. Mean EDLOS was 251 (SD = 164) min for TNK users versus 240 (SD = 148) min for ALT (p = 0.62). Mean DTN was 43 (SD = 25) min for TNK versus 46 (SD = 27) min for ALT users (p = 0.39). Mean DTN under 60 min was achieved in 86 (78.2%) patients and in 85 (76.5%) patients of the TNK and ALT groups, respectively (p = 1.0). DTN under 45 min was achieved in 65.4% and 58.6% (p = 0.65) of the TNK and ALT groups, respectively. DTG time was 114 (SD = 43) min for TNK versus 111 (58 = SD) min in the ALT group (p = 0.88). DTG under 90 min was achieved in 32% of the TNK group and 35% of the ALT group (p = 0.69). There were no differences in any of the clinical or safety outcomes between groups at 90 days.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The adoption of TNK during COVID-19 pandemic did not result in a change in EDLOS, DTN, or DTG times when compared to ALT in this cohort. Safety and clinical outcomes were similar between groups. Probably a greater benefit could have been seen in a drip and ship thrombolysis setting. Further research is needed to assess the potential advantages of TNK in drip and ship scenarios of IVT.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Tenecteplase (TNK) has demonstrated to be non-inferior to alteplase (ALT) for intravenous thrombolysis (IVT) in acute ischemic stroke (AIS). There are potential workflow benefits associated with TNK use, aiming to reduce patient length of stay in the emergency department. Our aim was to investigate whether the routine use of TNK during the COVID-19 pandemic influenced workflow times compared to historical use of ALT, while maintaining non-inferior clinical outcomes in a non-drip and ship scenario of a comprehensive stroke center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We included patients with AIS admitted from September 2019 to September 2022 and compared those treated with TNK during the COVID-19 pandemic to those treated with A","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":"102-109"},"PeriodicalIF":2.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11882161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease. 莫亚莫亚氏病血管重建手术中的 STA-MCA 旁路移植波形分析。
IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-03-28 DOI: 10.1159/000538548
Ryuzaburo Kochi, Atsushi Kanoke, Ryosuke Tashiro, Hiroki Uchida, Hidenori Endo

Background: Postoperative hyperperfusion syndrome (PHS) is a well-known complication following superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for moyamoya disease (MMD). The early detection of postoperative radiological hyperperfusion (PRH), characterized by a transient increase in local cerebral blood flow (CBF), is crucial for the early diagnosis of PHS. This study aimed to investigate the effectiveness of waveform analysis for early PRH detection.

Methods: We reviewed 52 consecutive patients who underwent STA-MCA bypass for MMD. Patients were divided into PRH and non-PRH groups based on the postoperative/preoperative CBF ratio. We collected the intraoperative bypass graft waveform and bypass flow data using a flowmeter. The pulsatile index (PI), an indicator of peripheral vascular resistance (PVR), was calculated from bypass flow data. Next, the newly proposed index of PVR, the ratio of the time from peak to 50% decay and to 100% decay (RT50), was calculated through waveform analysis. The values were then compared between the PRH and non-PRH groups.

Results: Twenty-seven of the 52 patients met the inclusion criteria. Fourteen of these 27 patients showed PRH. The RT50, but not the PI, was significantly higher in the PRH group. Linear regression analysis revealed a significant correlation between the RT50 and PI. In the receiver operating characteristic for predicting PRH, the area under the curve of RT50 was 0.750, with a cutoff value of 0.255, a sensitivity of 0.928, and a specificity of 0.500.

Conclusions: The RT50 obtained from waveform analysis is associated with PVR and can be useful for the early detection of PRH in patients with MMD.

背景:术后高灌注综合征(PHS)是众所周知的颞浅动脉(STA)-大脑中动脉(MCA)搭桥术治疗莫亚莫亚病(MMD)的并发症。术后放射学高灌注(PRH)的特征是局部脑血流(CBF)的短暂增加,早期发现PRH对于PHS的早期诊断至关重要。本研究旨在探讨波形分析在早期检测 PRH 方面的有效性:方法:我们回顾了 52 例连续接受 STA-MCA 分流治疗 MMD 的患者。根据术后/术前 CBF 比值将患者分为 PRH 组和非 PRH 组。我们使用流量计收集了术中旁路移植波形和旁路血流数据。根据旁路血流数据计算出外周血管阻力(PVR)指标--搏动指数(PI)。接着,通过波形分析计算出新提出的 PVR 指数,即从峰值到 50%衰减和到 100% 衰减的时间之比(RT50)。然后对 PRH 组和非 PRH 组的数值进行比较:52 名患者中有 27 名符合纳入标准。结果:52 名患者中有 27 人符合纳入标准,其中 14 人表现为 PRH。PRH 组的 RT50 值明显高于非 PRH 组。线性回归分析显示,RT50 和 PI 之间存在明显的相关性。在预测 PRH 的接收器操作特征中,RT50 的曲线下面积为 0.750,临界值为 0.255,灵敏度为 0.928,特异性为 0.500:通过波形分析获得的 RT50 与 PVR 相关,可用于 MMD 患者 PRH 的早期检测。
{"title":"Waveform Analysis of STA-MCA Bypass graft in Revascularization Surgery for Moyamoya Disease.","authors":"Ryuzaburo Kochi, Atsushi Kanoke, Ryosuke Tashiro, Hiroki Uchida, Hidenori Endo","doi":"10.1159/000538548","DOIUrl":"10.1159/000538548","url":null,"abstract":"<p><strong>Background: </strong>Postoperative hyperperfusion syndrome (PHS) is a well-known complication following superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for moyamoya disease (MMD). The early detection of postoperative radiological hyperperfusion (PRH), characterized by a transient increase in local cerebral blood flow (CBF), is crucial for the early diagnosis of PHS. This study aimed to investigate the effectiveness of waveform analysis for early PRH detection.</p><p><strong>Methods: </strong>We reviewed 52 consecutive patients who underwent STA-MCA bypass for MMD. Patients were divided into PRH and non-PRH groups based on the postoperative/preoperative CBF ratio. We collected the intraoperative bypass graft waveform and bypass flow data using a flowmeter. The pulsatile index (PI), an indicator of peripheral vascular resistance (PVR), was calculated from bypass flow data. Next, the newly proposed index of PVR, the ratio of the time from peak to 50% decay and to 100% decay (RT50), was calculated through waveform analysis. The values were then compared between the PRH and non-PRH groups.</p><p><strong>Results: </strong>Twenty-seven of the 52 patients met the inclusion criteria. Fourteen of these 27 patients showed PRH. The RT50, but not the PI, was significantly higher in the PRH group. Linear regression analysis revealed a significant correlation between the RT50 and PI. In the receiver operating characteristic for predicting PRH, the area under the curve of RT50 was 0.750, with a cutoff value of 0.255, a sensitivity of 0.928, and a specificity of 0.500.</p><p><strong>Conclusions: </strong>The RT50 obtained from waveform analysis is associated with PVR and can be useful for the early detection of PRH in patients with MMD.</p>","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11037892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation. 心房颤动患者卒中单元出院后坚持建议抗凝治疗的预测因素。
IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-02-12 DOI: 10.1159/000537781
Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler
<p><strong>Introduction: </strong>Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation management for physicians as well as for patients.</p><p><strong>Methods: </strong>We examined the adherence of secondary preventive anticoagulation in AF patients after re-integration in their social environment 6 to 12 weeks after stroke unit and rehabilitation clinic treatment and analyzed for predictors for adherence and non-adherence. We conducted a telephone survey in consecutive patients treated between January 2013 and December 2021 at our institutional stroke unit with an acute cerebrovascular ischemic event and we analyzed discharge letters of rehabilitation clinics of those patients not anticoagulated at follow-up. All patients had known or newly diagnosed AF and in all we had recommended secondary preventive anticoagulation.</p><p><strong>Results: </strong>Follow-up information about anticoagulant intake could be obtained in 1348 of 1685 patients (80.0%) treated within the study period. Anticoagulation rate was 91.5% with 83.6% of patients receiving DOACs and 7.9% receiving vitamin K antagonists (VKAs). Adherence to recommended anticoagulation was associated with intake of the recommended anticoagulant already at discharge (adjusted OR, 18.357; CI, 9.637 to 34.969), recommendation of a specific DOAC and dose (in contrast to "DOAC" as drug category) (adjusted OR, 2.971; CI, 1.173 to 7.255), a lower modified Rankin Scale at discharge (per point; adjusted OR, 0.813; CI, 0.663 to 0.996), younger age (per year; adjusted odds ratio [OR], 0.951; confidence interval [CI], 0.926 to 0.976), and the absence of peripheral vascular disease (adjusted OR, 0.359; CI, 0.173 to 0.746). In patients already anticoagulated at discharge adherence was 98.5%, irrespective of a patient's age, functional deficit at discharge, and peripheral vascular disease. Avoidable obstacles for non-adherence in patients not on anticoagulants at stroke unit discharge were (1) non-implementation of recommended anticoagulation by rehabilitation physicians predominantly in patients with moderate-severe or severe stroke disability (2.1%), (2) delegation of anticoagulation start from rehabilitation physicians to general practitioners/resident radiologists (1.3%), and (3) rejection of recommended anticoagulation because of patients' severe stroke disability (0.5%). Non-avoidable obstacles were contraindications to anticoagulation (2.1%) and patients' refusal (0.7%).</p><p><strong>Conclusions: </strong>Commencing drug administration already during stroke unit hospitalization and providing an explanation for the selection of the recommended anticoagulant in discharge letters ensures high adherence at patients' re-integration in their social environment after acute stroke treatment. If drug administration cannot be comme
导言:尽管直接口服抗凝药(DOACs)的引入简化了医生和患者的抗凝管理,但中风房颤(AF)患者不坚持推荐的二级预防性抗凝治疗是一个普遍现象:我们研究了房颤患者在卒中单元和康复诊所治疗 6 至 12 周后重新融入社会环境后的二级预防性抗凝治疗依从性,并分析了依从和不依从的预测因素。我们对 2013 年 1 月至 2021 年 12 月期间在本院卒中单元接受急性脑血管缺血性事件治疗的连续患者进行了电话调查,并对随访时未进行抗凝治疗的患者的康复诊所出院信进行了分析。所有患者都有已知或新诊断的房颤,我们都建议他们进行二级预防性抗凝治疗:在研究期间接受治疗的 1685 名患者中,有 1348 人(80.0%)获得了服用抗凝剂的随访信息。抗凝率为 91.5%,其中 83.6% 的患者服用 DOAC,7.9% 的患者服用维生素 K 拮抗剂 (VKAs)。坚持推荐的抗凝治疗与以下因素有关:出院时已摄入推荐的抗凝剂(调整 OR,18.357;CI,9.637 至 34.969);推荐特定的 DOAC 和剂量(与作为药物类别的 "DOAC "相反)(调整 OR,2.971;CI,1.173 至 7.255);修改后的兰格氏评分较低。255)、出院时修改后的兰金量表较低(每点;调整后 OR,0.813;CI,0.663 至 0.996)、年龄较小(每年;调整后几率比 [OR],0.951;置信区间 [CI],0.926 至 0.976)以及无外周血管疾病(调整后 OR,0.359;CI,0.173 至 0.746)。在出院时已接受抗凝治疗的患者中,无论患者的年龄、出院时的功能缺陷和外周血管疾病如何,坚持治疗的比例均为 98.5%。卒中单元出院时未接受抗凝治疗的患者未坚持治疗的可避免障碍是:(1)康复科医生未执行建议的抗凝治疗,主要是中重度或重度卒中残疾患者(2.1%);(2)康复科医生将抗凝治疗的起始时间委托给全科医生/放射科住院医师(1.3%);(3)因患者严重卒中残疾而拒绝接受建议的抗凝治疗(0.5%)。不可避免的障碍是抗凝禁忌症(2.1%)和患者拒绝(0.7%):结论:在卒中单元住院期间就开始用药,并在出院信中说明选择推荐的抗凝药物,可确保患者在急性卒中治疗后重新融入社会环境时高度依从。如果不能在出院前开始用药,则应由卒中医生对康复医生进行教育,并让卒中医生参与到卒中后的决策过程中,这可能会减少可避免的障碍。
{"title":"Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation.","authors":"Theresa Frank, Jens Neumann, Anne Assmann, Stefanie Schreiber, Aiden Haghikia, Maria Barleben, Michael Sailer, Michael Goertler","doi":"10.1159/000537781","DOIUrl":"10.1159/000537781","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Non-adherence to recommended secondary preventive anticoagulation in stroke patients with atrial fibrillation (AF) is a common phenomenon although the introduction of direct oral anticoagulants (DOACs) has simplified anticoagulation management for physicians as well as for patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We examined the adherence of secondary preventive anticoagulation in AF patients after re-integration in their social environment 6 to 12 weeks after stroke unit and rehabilitation clinic treatment and analyzed for predictors for adherence and non-adherence. We conducted a telephone survey in consecutive patients treated between January 2013 and December 2021 at our institutional stroke unit with an acute cerebrovascular ischemic event and we analyzed discharge letters of rehabilitation clinics of those patients not anticoagulated at follow-up. All patients had known or newly diagnosed AF and in all we had recommended secondary preventive anticoagulation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Follow-up information about anticoagulant intake could be obtained in 1348 of 1685 patients (80.0%) treated within the study period. Anticoagulation rate was 91.5% with 83.6% of patients receiving DOACs and 7.9% receiving vitamin K antagonists (VKAs). Adherence to recommended anticoagulation was associated with intake of the recommended anticoagulant already at discharge (adjusted OR, 18.357; CI, 9.637 to 34.969), recommendation of a specific DOAC and dose (in contrast to \"DOAC\" as drug category) (adjusted OR, 2.971; CI, 1.173 to 7.255), a lower modified Rankin Scale at discharge (per point; adjusted OR, 0.813; CI, 0.663 to 0.996), younger age (per year; adjusted odds ratio [OR], 0.951; confidence interval [CI], 0.926 to 0.976), and the absence of peripheral vascular disease (adjusted OR, 0.359; CI, 0.173 to 0.746). In patients already anticoagulated at discharge adherence was 98.5%, irrespective of a patient's age, functional deficit at discharge, and peripheral vascular disease. Avoidable obstacles for non-adherence in patients not on anticoagulants at stroke unit discharge were (1) non-implementation of recommended anticoagulation by rehabilitation physicians predominantly in patients with moderate-severe or severe stroke disability (2.1%), (2) delegation of anticoagulation start from rehabilitation physicians to general practitioners/resident radiologists (1.3%), and (3) rejection of recommended anticoagulation because of patients' severe stroke disability (0.5%). Non-avoidable obstacles were contraindications to anticoagulation (2.1%) and patients' refusal (0.7%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Commencing drug administration already during stroke unit hospitalization and providing an explanation for the selection of the recommended anticoagulant in discharge letters ensures high adherence at patients' re-integration in their social environment after acute stroke treatment. If drug administration cannot be comme","PeriodicalId":45709,"journal":{"name":"Cerebrovascular Diseases Extra","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10923591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cerebrovascular Diseases Extra
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1